The estimated Net Worth of Steven Arch Venture Fund Vi... is at least $4.29 millió dollars as of 15 June 2015. Steven Vi owns over 72,750 units of Pulmatrix Inc stock worth over $4,287,105 and over the last 9 years Steven sold PULM stock worth over $0.
Steven has made over 1 trades of the Pulmatrix Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Steven bought 72,750 units of PULM stock worth $500,520 on 15 June 2015.
The largest trade Steven's ever made was buying 72,750 units of Pulmatrix Inc stock on 15 June 2015 worth over $500,520. On average, Steven trades about 36,375 units every 0 days since 2015. As of 15 June 2015 Steven still owns at least 2,286,456 units of Pulmatrix Inc stock.
You can see the complete history of Steven Vi stock trades at the bottom of the page.
Over the last 9 years, insiders at Pulmatrix Inc have traded over $4,537,500 worth of Pulmatrix Inc stock and bought 290,998 units worth $2,002,066 . The most active insiders traders include Steven Gillis, Terrance Mcguire és Innovative Sciences, Inc. O.... On average, Pulmatrix Inc executives and independent directors trade stock every 92 days with the average trade being worth of $521,728. The most recent stock trade was executed by David L. Hava on 20 March 2017, trading 2,263 units of PULM stock currently worth $5,001.
pulmatrix is a clinical stage biotechnology company with an inhaled dry powder platform advancing a new generation of inhaled therapeutics. the platform, called isperse (inhaled small particles easily respirable and emitted), represents a new paradigm in inhaled drug delivery based on unique properties: dense, high drug load engineered particles with highly efficient dispersibility and delivery to the airways. the isperse powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance.
Pulmatrix Inc executives and other stock owners filed with the SEC include: